Zur Behandlung der chronischen Polyarthritis: Offene Paralleluntersuchung der nichtsteroidalen Antirheumatika Piroxicam und Diclofenac

Publisher Website
Google Scholar
Abstract
Piroxicam and diclofenac were compared for 4 wk in an open parallel study in 20 rheumatoid arthritis patients each. Both preparations showed good efficacy and were well tolerated, piroxicam appearing to be slightly superior in both respects. Piroxicam exercised a significant action on the inflammation-specific parameters (reduction of BSR [blood sedimentation rate] by 6.15 mm maximum and of the .alpha.2-globulin fraction by 0.75%), but diclofenac did not. Another advantage of piroxicam is its low effective dosage level achieved by a single daily dose.

This publication has 0 references indexed in Scilit: